Literature DB >> 35348079

Pearls from a Clinician-Researcher in an Integrated Health care Delivery System.

Kate Michi Ettinger1, Vivian M Ettinger1, Marc G Jaffe2,3, David A Schroeder4, Joan C Lo3,5,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 35348079      PMCID： PMC8817907          DOI： 10.7812/TPP/20.305

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


× No keyword cloud information.
  17 in total

1.  Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.

Authors:  B Ettinger; H K Genant; P Steiger; P Madvig
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

2.  Reduced mortality associated with long-term postmenopausal estrogen therapy.

Authors:  B Ettinger; G D Friedman; T Bush; C P Quesenberry
Journal:  Obstet Gynecol       Date:  1996-01       Impact factor: 7.661

3.  Triamterene-induced nephrolithiasis.

Authors:  B Ettinger; E Weil; N S Mandel; S Darling
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

4.  Proposed pathogenesis for atypical femoral fractures: lessons from materials research.

Authors:  B Ettinger; D B Burr; R O Ritchie
Journal:  Bone       Date:  2013-02-16       Impact factor: 4.398

5.  Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture.

Authors:  Bruce Ettinger; Cynthia A Stuenkel; Peter F Schnatz
Journal:  Menopause       Date:  2013-10       Impact factor: 2.953

6.  Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.

Authors:  Bruce Ettinger; Kristine E Ensrud; Robert Wallace; Karen C Johnson; Steven R Cummings; Vladimir Yankov; Eric Vittinghoff; Deborah Grady
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

7.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

8.  Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

Authors:  Bruce Ettinger; Deborah Grady; Anna N A Tosteson; Alice Pressman; Judith L Macer
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

9.  Cyclic hormone replacement therapy using quarterly progestin.

Authors:  B Ettinger; J Selby; J T Citron; A Vangessel; V M Ettinger; M R Hendrickson
Journal:  Obstet Gynecol       Date:  1994-05       Impact factor: 7.661

10.  Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.

Authors:  J C Lo; C D Grimsrud; S M Ott; M Chandra; R L Hui; B Ettinger
Journal:  Osteoporos Int       Date:  2019-09-25       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.